Alembic Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NSEI:APLLTD Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
18 Mar 25	Buy₹1,248,783	Chirayu Amin	Individual	1,500	₹832.52
17 Mar 25	Buy₹4,818,674	Chirayu Amin	Individual	5,832	₹826.25
27 Feb 25	Buy₹38,912,523	Chirayu Amin	Individual	50,000	₹778.25
25 Feb 25	Buy₹5,925,290	Chirayu Amin	Individual	7,426	₹797.91
21 Feb 25	Buy₹3,423,686	Chirayu Amin	Individual	4,247	₹806.14
20 Feb 25	Buy₹778,630	Chirayu Amin	Individual	959	₹811.92
14 Feb 25	Buy₹8,129,009	Chirayu Amin	Individual	10,000	₹812.90
13 Feb 25	Buy₹20,860,900	Chirayu Amin	Individual	24,773	₹842.08

Insider Trading Volume

Insider Buying: APLLTD insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of APLLTD?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	855	0.000435%
State or Government	1,539,960	0.783%
Individual Insiders	11,491,140	5.85%
General Public	25,887,633	13.2%
Institutions	31,458,757	16%
Private Companies	126,184,779	64.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 86.39% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
64.2%	Nirayu Pvt. Ltd.	126,133,079	₹106.8b	0%	no data
4.38%	DSP BlackRock Investment Managers Pvt. Ltd.	8,610,979	₹7.3b	3.69%	0.66%
4.32%	Life Insurance Corporation of India, Asset Management Arm	8,495,125	₹7.2b	-0.09%	0.05%
2.55%	Chirayu Amin	5,020,516	₹4.2b	19.8%	no data
1.77%	Kotak Mahindra Asset Management Company Limited	3,483,766	₹2.9b	-6.28%	0.11%
1.53%	Malika Amin	3,005,730	₹2.5b	0%	no data
0.96%	The Vanguard Group, Inc.	1,881,783	₹1.6b	0.66%	no data
0.78%	Investor Education and Protection Fund (IEPF)	1,539,960	₹1.3b	-0.16%	no data
0.74%	Axis Asset Management Company Limited	1,446,459	₹1.2b	0%	0.06%
0.65%	ICICI Prudential Asset Management Company Limited	1,272,351	₹1.1b	96.8%	0.02%
0.61%	Edelweiss Asset Management Limited	1,200,048	₹1.0b	3.37%	0.14%
0.59%	Pranav Amin	1,160,200	₹982.0m	0%	no data
0.55%	Dimensional Fund Advisors LP	1,071,808	₹907.2m	2.45%	no data
0.51%	Shaunak Amin	1,007,080	₹852.4m	0%	no data
0.51%	Udit Amin	1,006,980	₹852.3m	0%	no data
0.49%	BlackRock, Inc.	966,047	₹817.7m	0.38%	no data
0.26%	Baroda BNP Paribas Mutual Fund	512,976	₹434.2m	3.64%	0.19%
0.2%	Norges Bank Investment Management	397,336	₹336.3m	0%	no data
0.16%	Mirae Asset Global Investments Co., Ltd.	311,808	₹263.9m	1,130%	no data
0.16%	Schroder Investment Management (Singapore) Ltd.	309,118	₹261.6m	0%	0.02%
0.14%	HDFC Asset Management Company Limited	271,876	₹230.1m	3.79%	no data
0.12%	Aditya Birla Sun Life AMC Limited	240,291	₹203.4m	-68.2%	0.01%
0.11%	BNY Asset Management	211,990	₹179.4m	0.13%	no data
0.076%	UTI Asset Management Company Limited	150,000	₹127.0m	24.5%	0.01%
0.055%	DSP Asset Managers Pvt. Ltd	108,938	₹92.2m	22.1%	0.09%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/04/12 20:45
End of Day Share Price	2025/04/11 00:00
Earnings	2024/12/31
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Alembic Pharmaceuticals Limited is covered by 24 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Sarabjit Nangra	Angel Broking Private Limited
null null	Antique Stockbroking Ltd.
Harith Ahamed	Avendus Spark